Drug recovery from a new oral fluid collection device was assessed. The evaluation was performed in vitro at three physiologically relevant concentrations for the following substances: amphetamine, methamphetamine, morphine, codeine, cocaine, benzoylecgonine, methadone, oxazepam, and A%tetrahydrocannabinol (THC). Drug-free and drug-fortified controls were prepared and their concentration verified by liquid chromatography-tandem mass spectrometry. Aliquots of the controls were lhen "collected" with the device (n = 3) using the manufacturer's recommended procedure. Collected samples were stored for 12 h Io simulate shipping before analysis. Fresh, non-"collected" aliquots of each pool (n = 3) were concurrently analyzed. The drug recoveries from the Quantisal were expressed as a mean percentage of the concurrently analyzed aliquots that were not subjected to device collection. Recoveries for oxazepam exceeded 97%, for amphetamine and methamphetamine exceeded 93%, and for opioids all exceeded 91%. The recoveries of cocaine were > 91% and > 82% for its polar metaboiite, benzoylecgonine.
detected and reported in OF, including ethanol, methamphetamine, amphetamine, barbiturates, benzodiazepines, heroin, cocaine, and Ag-tetrahydrocannabinol (THC) (3) . In many cases, the concentrations of these drugs in OF often exceeded those in blood (4) . However, it has been demonstrated that the collection process has a significant effect on the potential to detect and quantify drugs in OF (5) . Therefore, we performed an evaluation of a new OF collection device, the Immunalysis Quantisal (Quantisal). The Quantisal collector is a simple device with a plastic handle, a "paddle", and a collectionvolume indicator. The device is placed under the donor's tongue, and the manufacturer strongly recommends not chewing or sucking on the pad and not moving the pad while the OF is being collected. Reported collection times vary from
Introduction Experimental
Use of the oral fluid (OF) (frequently referred to as "saliva") as a drug-testing specimen has increased significantly in the last decade. Despite its use for therapeutic drug monitoring for over 30 years (1) , its introduction into the fields of forensic science and toxicology occurred much more recently. The advantages of OF are documented in the scientific literature and include ease of collection, observed collection, and difficulty of adulteration. The detection times for drugs in OF are approximately equal to those in blood, making OF a potential specimen for predicting drug-impairment (2) . Many drugs of interest in the forensic and criminal justice settings have been The goal of this research was to assess the recovery of commonly abused and detected drugs from the Quantisal OF collector. Recovery of the following substances was evaluated: amphetamine, methamphetamine, cocaine, benzoylecgonine (BE), THC, morphine, codeine, 6-monoacetylmorphine (6-MAM), methadone, and oxazepam. The drugs were divided into four groups (see below) and fortified into the pools. To achieve this goal, drug-free synthetic OF (Saliva Subtitute TM, Roxane Laboratories, Inc., Columbus, OH) was diluted 3:1 with deionized water and fortified with the target analytes at three physiologically relevant concentrations (Table I ). In addition, a drug-free negative control was prepared.
The concentration of each control solution was verified using multipoint calibration and liquid chromatographytandem mass spectrometry (LC-MS-MS) replicate (n = 3) anal-ysis of each pool at each concentration, except for the negative control (n = 1).
Following concentration verification, control samples were "collected" by inserting the Quantisal collectors into silanized test tubes containing an aliquot of the control. Collection continued until the "volume adequacy indicator" turned completely blue, signifying that I mL of OF had been collected. The collector paddle was then placed into the transport tube, and the tube and its contents were gently mixed by hand as recommended by the manufacturer.
To simulate shipment, the transport tubes containing the saturated collector, were stored in the dark at room temperature for 12 h. After 12 h, the collector pad was separated from its plastic stem, and a serum separator was inserted into the tube. The serum separator compressed the collection pad to the bottom of the tube and provided a clear filtrate of OF and collector buffer. The filtrates were immediately decanted into silanized tubes for storage prior to analysis.
All collected solutions were analyzed by LC-MS-MS (n = 3), and their concentrations were compared to those of their corresponding controls. The control pools (n = 3) were not "collected" by the device, but rather were extracted and analyzed as "neat" OF. Recovery was calculated by comparing the mean concentration obtained from each device to the mean concentration of each neat control (at its respective concentration) and reported as percent recovery. Calibration curves were prepared, and quantitation assumed that the Quantisal collected I mL of OF, which was subsequently diluted 1:4 with the collection buffer.
Group I: amphetamine, cocaine, and morphine
Pools were prepared by fortifying the drugs at the desired concentration (Table I) . Multipoint calibration curves ranged from 5 to 200 nglmL. The respective deuterated internal standard for each drug was added to generate linear calibration curves (weighted I/x). The samples were extracted with solidphase extraction (SPE) Oasis MCX cartridges (Waters, Milford, MA) as proposed by Wood et al. (6) . The drugs were analyzed using a Thermo-Finnigan TSQ 7000 (triple-quadrupole MS) coupled with an Agilent 1100 series LC. For all analyses, except THC, electrospray in the positive ionization mode (ES+) was used, the instrument conditions were optimized, and multiple reaction monitoring detection was used. Results presented as mean percentage of the control value (n = 3 for Quantisal, n = 5 for the other devices).
Group 2: methamphetamine, BE, and oxazepam
Pools were prepared by fortifying the drugs at the desired concentration (Table I) . Multipoint calibration curves ranged from 2.5 to 100 ng/mL. The respective deuterated internal standard for each drug was added to generate linear calibration curves (weighted 1/x). Extractions were performed using mixed-mode bonded silica solid-phase extraction cartridges (Bond Elut Certify, Varian, Harbor City, CA). This column was selected to ensure efficient extraction of oxazepam (7).
Group 3: methadone, codeine, and 6-MAM Pools were prepared by fortifying the drugs at the desired concentration (Table I) . Multipoint calibration curves ranged from 1 to 100 ng/mL, and the respective deuterated internal standard for each drug was added to generate linear calibration curves (weighted 1/x). The extraction and analysis of these drugs paralleled that of group 1 (6).
Group 4: THC performance
Because of the problematic stability and recovery of THC, it was considered separately. Pools were fortified at the desired concentration (Table I) . The multipoint calibration curve ranged from 0.5 to 50 ng/mL. A deuterated internal standard for THC-d3 was added to generate quadratic calibration curves (weighted 1/x). Liquid-liquid extraction using hexane/ethyl acetate (9:1, v/v) was performed as previously developed in our laboratory for the analysis of plasma, urine, and blood (8) . A quadrupoletime-of-flight instrument (Q-TOF) (Applied Biosystems/MSD Sciex, Foster City, CA) was used with ES+ ionization and positive ion detection of the product ions.
Results and Discussion
Once the control pool concentrations were verified, the analysis of the collected samples versus pools was performed. No interfering substances were found in the drug-free or fortified pools or in the collected controls. According to Wood et al. (6) , an efficient clean-up method is required in order to avoid interferences from the buffer solution present in the OF collector devices. The use of different types of mixed-mode solidphase cartridges was able to eliminate the potential interferences and, at the same time, allowed us to recover the analytes of interest. Table I shows the Quantisal recovery versus control for each compound. As Table I shows, for all drugs, the recovery exceeded 85% with three exceptions. At the highest concentration of the polar cocaine metabolite (BE) recovery was 82.7%, and at the low and high concentrations of THC, recoveries were 84.0% and 81.3%, respectively. The n = 3 replicates at each concentration of each drug were used to evaluate precision and the coefficient of variation (CV) calculated. In all cases, the CV was less than 8%, except for one concentration (25 ng/mL) of methamphetamine (8.9%) and one (2 ng/mL) of THC (12.9%) (data not shown).
Compared with previously evaluated OF collection devices, a significant improvement in drug recovery was observed with the Quantisal. Table I compares the recoveries from the Quantisal with those previously reported from other OF collection devices (9) . Both cocaine and BE showed recoveries similar to previously evaluated collectors. For the other drugs studied, however, the Quantisal had substantially improved recovery. The recovery of amphetamine and methamphetamine from the Quantisal device was at least 93%, and recovery of these drugs from other devices did not exceed 59%. Similarly, the recovery of morphine and codeine from the Quantisal ranged from 91.9% to 100%, whereas those from the other devices were typically about 30% and never exceeded 50%. 6-MAM, methadone, and oxazepam were not evaluated in the previous studies. And although not shown in the table, the recovery of THC from OF collection devices was reported to be so poor that no successful data were obtained (3). Conversely, recoveries from the Quantisal were high and reproducible.
Conclusions
The in vitro drug recoveries from the Quantisal OF collector were quite consistent with the precision of the replicate analysis (n = 3) typically within the precision of the analytical methods used. Recoveries of abused drugs from the Quantisal were either consistent with those of other devices (amphetamine and methamphetamine) or, for most drugs, (opiates, cocaine, THC) much improved. Recovery of THC, the most commonly encountered drug in forensic analysis, was substantially superior to that previously reported. In addition, the Quantisal buffer in combination with specimen preparation by liquid-liquid or solid-phase extraction did not contribute to any analytical interferences or ion-suppression when using LC-MS-MS analysis of the compounds of interest. This has been a problem reported with other OF collection devices (10) .
